ADE000968
1H-pyrrolo[3,2-b]pyridine
AldrichCPR
Faça loginpara ver os preços organizacionais e de contrato
About This Item
Fórmula empírica (Notação de Hill):
C7H6N2
Número CAS:
Peso molecular:
118.14
Número MDL:
Código UNSPSC:
12352200
ID de substância PubChem:
Produtos recomendados
![1H-pyrrolo[3,2-c]pyridine AldrichCPR](/deepweb/assets/sigmaaldrich/product/structures/291/250/879d6f32-75bf-4a4a-a366-18cbd62dcc37/640/879d6f32-75bf-4a4a-a366-18cbd62dcc37.png)
![1H-Pyrrolo[2,3-c]pyridine AldrichCPR](/deepweb/assets/sigmaaldrich/product/structures/332/393/b23058ac-c477-42b5-9890-dc5c2af5cec7/640/b23058ac-c477-42b5-9890-dc5c2af5cec7.png)
![4-Iodo-1H-pyrrolo[2,3-b]pyridine AldrichCPR](/deepweb/assets/sigmaaldrich/product/structures/296/181/125fbe1d-3d80-4d64-b93a-f92f6ce766ba/640/125fbe1d-3d80-4d64-b93a-f92f6ce766ba.png)
![1H-Pyrrolo[2,3-b]pyridine-2-carboxylic acid AldrichCPR](/deepweb/assets/sigmaaldrich/product/structures/238/208/7cc66a5b-8290-425e-8cbf-2364ca9114e9/640/7cc66a5b-8290-425e-8cbf-2364ca9114e9.png)
![1H-Pyrrolo[2,3-b]pyridine-5-carbonitrile AldrichCPR](/deepweb/assets/sigmaaldrich/product/structures/505/605/6b5b15eb-77f0-40a2-bd37-fff8f3526e8e/640/6b5b15eb-77f0-40a2-bd37-fff8f3526e8e.png)
forma
solid
cadeia de caracteres SMILES
c1cnc2cc[nH]c2c1
InChI
1S/C7H6N2/c1-2-6-7(8-4-1)3-5-9-6/h1-5,9H
chave InChI
XWIYUCRMWCHYJR-UHFFFAOYSA-N
Outras notas
Please note that Sigma-Aldrich provides this product to early discovery researchers as part of a collection of unique chemicals. Sigma-Aldrich does not collect analytical data for this product. Buyer assumes responsibility to confirm product identity and/or purity. All sales are final.
NOTWITHSTANDING ANY CONTRARY PROVISION CONTAINED IN SIGMA-ALDRICH′S STANDARD TERMS AND CONDITIONS OF SALE OR AN AGREEMENT BETWEEN SIGMA-ALDRICH AND BUYER, SIGMA-ALDRICH SELLS THIS PRODUCT "AS-IS" AND MAKES NO REPRESENTATION OR WARRANTY WHATSOEVER WITH RESPECT TO THIS PRODUCT, INCLUDING ANY (A) WARRANTY OF MERCHANTABILITY; (B) WARRANTY OF FITNESS FOR A PARTICULAR PURPOSE; OR (C) WARRANTY AGAINST INFRINGEMENT OF INTELLECTUAL PROPERTY RIGHTS OF A THIRD PARTY; WHETHER ARISING BY LAW, COURSE OF DEALING, COURSE OF PERFORMANCE, USAGE OF TRADE OR OTHERWISE.
NOTWITHSTANDING ANY CONTRARY PROVISION CONTAINED IN SIGMA-ALDRICH′S STANDARD TERMS AND CONDITIONS OF SALE OR AN AGREEMENT BETWEEN SIGMA-ALDRICH AND BUYER, SIGMA-ALDRICH SELLS THIS PRODUCT "AS-IS" AND MAKES NO REPRESENTATION OR WARRANTY WHATSOEVER WITH RESPECT TO THIS PRODUCT, INCLUDING ANY (A) WARRANTY OF MERCHANTABILITY; (B) WARRANTY OF FITNESS FOR A PARTICULAR PURPOSE; OR (C) WARRANTY AGAINST INFRINGEMENT OF INTELLECTUAL PROPERTY RIGHTS OF A THIRD PARTY; WHETHER ARISING BY LAW, COURSE OF DEALING, COURSE OF PERFORMANCE, USAGE OF TRADE OR OTHERWISE.
Informações legais
Product of Adesis
Palavra indicadora
Danger
Frases de perigo
Declarações de precaução
Classificações de perigo
Acute Tox. 4 Oral - Eye Dam. 1
Código de classe de armazenamento
11 - Combustible Solids
Ponto de fulgor (°F)
Not applicable
Ponto de fulgor (°C)
Not applicable
Escolha uma das versões mais recentes:
Certificados de análise (COA)
Lot/Batch Number
Lamentamos, não temos COA para este produto disponíveis online no momento.
Se precisar de ajuda, entre em contato Atendimento ao cliente
Já possui este produto?
Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.
Taleen S Der-Ghazarian et al.
ACS chemical neuroscience, 10(7), 3271-3283 (2019-05-03)
5-HT1B receptors (5-HT1BRs) modulate psychostimulant reward and incentive motivation in rodents. Here we investigated the effects of the 5-HT1BR agonist CP94253 (10 mg/kg, IP) on the acquisition and expression of methamphetamine (Meth) conditioned place preference (CPP) in C57BL/6 male mice.
Jessica Karlsson et al.
PloS one, 10(11), e0142711-e0142711 (2015-11-14)
Combined fatty acid amide hydrolase (FAAH) and cyclooxygenase (COX) inhibition is a promising approach for pain-relief. The Flu-AM1 and Ibu-AM5 derivatives of flurbiprofen and ibuprofen retain similar COX-inhibitory properties and are more potent inhibitors of FAAH than the parent compounds.
Bruno Aleksander Martek et al.
Drug testing and analysis, 11(4), 617-625 (2019-02-08)
The high frequency of the synthetic cannabinoid receptor agonists (SCRAs) emergence renders this group of new psychoactive compounds particularly demanding in terms of detection, identification, and responding. Without the available reference material, one of the specific problems is differentiation and
Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.
Entre em contato com a assistência técnica